Lucira Health Inc. (LHDX) is priced at $10.91 after the most recent trading session. At the very opening of the session, the stock price was $9.11 and reached a high price of $12.14, prior to closing the session it reached the value of $8.59. The stock touched a low price of $8.51.
Recently in News on April 12, 2021, FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.. Reports Preliminary 2021 First Quarter Revenue and Business Update. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Lucira Health Inc. shares are logging -71.28% during the 52-week period from high price, and 36.65% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.98 and $37.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 10213410 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Lucira Health Inc. (LHDX) recorded performance in the market was -56.33%. At the time of this writing, the total market value of the company is set at 408.69M, as it employees total of 57 workers.
Lucira Health Inc. (LHDX) in the eye of market guru’s
During the last month, 1 analysts gave the Lucira Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Lucira Health Inc. (LHDX): Stocks Technical analysis and Trends
In the last 20 days, the company’s Stochastic %K was 14.91% and its Stochastic %D was recorded 7.20%.
If we look into the earlier routines of Lucira Health Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -56.33%. The shares increased approximately by 0.00% in the 7-day charts and went up by -30.15% in the period of the last 30 days.